For the year ending 2025-12-31, TEVJF has $40,748M in assets. $32,834M in debts. $3,556M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 3,556 | 3,300 | 3,226 | 2,801 |
| Accounts receivables, net of allowance for credit losses of 81million and 78million as of december31, 2025 and december31, 2024, respectively | 3,709 | 3,059 | 3,408 | 3,696 |
| Inventories | 3,179 | 3,007 | 4,021 | 3,833 |
| Prepaid expenses | 1,122 | 1,006 | 1,255 | 1,162 |
| Other current assets | 539 | 409 | 504 | 549 |
| Assets held for sale | 1,842 | 1,771 | 70 | 10 |
| Total current assets | 13,946 | 12,552 | 12,485 | 12,051 |
| Deferred income taxes | 2,191 | 1,799 | 1,812 | 1,453 |
| Othernon-currentassets | 405 | 462 | 470 | 441 |
| Property, plant and equipment, net | 4,080 | 4,581 | 5,750 | 5,739 |
| Operating lease right-of-use assets | 345 | 367 | 397 | 419 |
| Accumulated amortization-In Process Research And Development | 0 | 0 | 0 | - |
| Gross carrying amount net of impairment | 17,111 | 16,716 | 18,930 | 19,131 |
| Accumulated amortization | 13,330 | 12,298 | 13,543 | 12,861 |
| Identifiable intangible assets, net | 3,781 | 4,418 | 5,387 | 6,270 |
| Goodwill | 16,000 | 15,147 | 17,177 | 17,633 |
| Total assets | 40,748 | 39,326 | 43,479 | 44,006 |
| Short-term debt | 1,820 | 1,781 | 1,672 | 2,109 |
| Sales reserves and allowances | 4,143 | 3,678 | 3,535 | 3,750 |
| Accounts payables | 2,531 | 2,203 | 2,602 | 1,887 |
| Employee-related obligations | 739 | 624 | 611 | 566 |
| Accrued expenses | 2,687 | 2,792 | 2,771 | 2,151 |
| Other current liabilities | 1,182 | 1,020 | 1,056 | 1,005 |
| Liabilities held for sale | 354 | 698 | - | - |
| Total current liabilities | 13,456 | 12,796 | 12,247 | 11,469 |
| Deferred income taxes | 296 | 483 | 606 | 548 |
| Other taxes and long-term liabilities | 3,808 | 4,028 | 4,019 | 3,847 |
| Senior notes and loans | 14,986 | 16,002 | 18,161 | 19,103 |
| Operating lease liabilities | 288 | 296 | 320 | 349 |
| Total long-term liabilities | 19,379 | 20,809 | 23,106 | 23,846 |
| Total liabilities | 32,834 | 33,606 | 35,353 | 35,315 |
| Redeemable non-controlling interests | - | 340 | - | - |
| Ordinary shares of nis 0.10 par value per share december31, 2025 and december31, 2024 authorized 2,495million shares issued 1,257million shares and 1,240million shares, respectively | 58 | 58 | 57 | 57 |
| Additionalpaid-incapital | 28,133 | 27,764 | 27,807 | 27,688 |
| Accumulated deficit | -13,762 | -15,173 | -13,534 | -12,882 |
| Accumulated other comprehensive loss | -2,391 | -3,148 | -2,697 | -2,838 |
| Treasury shares as of december31, 2025 and december31, 2024 107million ordinary shares | 4,128 | 4,128 | 4,128 | 4,128 |
| Stockholders' equity attributable to teva shareholders | 7,910 | 5,373 | 7,506 | 7,897 |
| Non-controlling interests | 4 | 7 | 620 | 794 |
| Total equity | 7,914 | 5,380 | 8,126 | 8,691 |
| Total liabilities, redeemable non-controlling interests and equity | 40,748 | 39,326 | 43,479 | 44,006 |
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)